Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$40.9 - $50.42 $3,190 - $3,932
-78 Reduced 19.65%
319 $13,000
Q2 2022

Aug 15, 2022

BUY
$42.98 - $49.77 $3,610 - $4,180
84 Added 26.84%
397 $19,000
Q1 2022

May 10, 2022

BUY
$42.23 - $54.3 $2,153 - $2,769
51 Added 19.47%
313 $15,000
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $4,201 - $4,687
83 Added 46.37%
262 $15,000
Q2 2021

Aug 13, 2021

SELL
$46.28 - $52.75 $1,064 - $1,213
-23 Reduced 11.39%
179 $9,000
Q1 2021

May 13, 2021

BUY
$46.25 - $56.02 $1,942 - $2,352
42 Added 26.25%
202 $10,000
Q4 2020

Feb 08, 2021

BUY
$46.09 - $54.74 $7,374 - $8,758
160 New
160 $8,000
Q3 2020

Nov 06, 2020

SELL
$42.51 - $52.42 $6,546 - $8,072
-154 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$33.17 - $41.6 $4,975 - $6,240
-150 Reduced 49.34%
154 $6,000
Q4 2019

Feb 05, 2020

BUY
$25.41 - $43.1 $7,724 - $13,102
304 New
304 $10,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.